Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$32.43
-0.30-0.92%
At close: -
$33.00
0.571.76%
After Hours: 4:30 PM EDT
Comments
Loading...
Cytokinetics Analyst Ratings and Price Targets | NASDAQ:CYTK | Benzinga
Cytokinetics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cytokinetics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Mizuho
Needham
Barclays
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Cytokinetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/09/2025 | Buy Now | — | JP Morgan | Tessa Romero60% | $71 → $53 | Maintains | Overweight | Get Alert |
| 05/29/2025 | Buy Now | — | Mizuho | Salim Syed44% | $103 → $84 | Maintains | Outperform | Get Alert |
| 05/14/2025 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2025 | Buy Now | — | Barclays | Gena Wang51% | $55 → $53 | Maintains | Overweight | Get Alert |
| 05/07/2025 | Buy Now | — | RBC Capital | Leonid Timashev41% | $82 → $80 | Maintains | Outperform | Get Alert |
| 05/07/2025 | Buy Now | — | Citigroup | David Lebowitz55% | $86 → $80 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | — | UBS | Ashwani Verma48% | $47 → $41 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 04/24/2025 | Buy Now | — | Barclays | Gena Wang51% | → $55 | Initiates | → Overweight | Get Alert |
| 04/21/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2025 | Buy Now | — | B of A Securities | Jason Zemansky77% | $62 → $54 | Maintains | Neutral | Get Alert |
| 04/15/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2025 | Buy Now | — | JMP Securities | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/08/2025 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2025 | Buy Now | — | Citizens Capital Markets | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $70 → $67 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/07/2025 | Buy Now | — | Citigroup | David Lebowitz55% | → $86 | Initiates | → Buy | Get Alert |
| 02/07/2025 | Buy Now | — | JMP Securities | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/06/2025 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | Buy Now | — | Stifel | James Condulis49% | → $80 | Initiates | → Buy | Get Alert |
| 01/21/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/14/2025 | Buy Now | — | JMP Securities | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/14/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | — | Reiterates | Buy → Buy | Get Alert |
| 12/23/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2024 | Buy Now | — | RBC Capital | Leonid Timashev41% | $80 → $82 | Maintains | Outperform | Get Alert |
| 12/03/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/02/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/02/2024 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2024 | Buy Now | — | Mizuho | Salim Syed44% | $99 → $103 | Maintains | Outperform | Get Alert |
| 11/20/2024 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 11/19/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/11/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2024 | Buy Now | — | RBC Capital | Leonid Timashev41% | → $80 | Initiates | → Outperform | Get Alert |
| 11/07/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 10/18/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 10/17/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 10/17/2024 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $120 | Maintains | Buy | Get Alert |
| 09/30/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $65 → $71 | Maintains | Overweight | Get Alert |
| 09/04/2024 | Buy Now | — | JMP Securities | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/03/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | Buy Now | — | Goldman Sachs | Paul Choi58% | $85 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 08/12/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | — | Needham | Serge Belanger67% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $77 → $65 | Maintains | Overweight | Get Alert |
| 06/17/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | — | B. Riley Securities | Mayank Mamtani71% | $122 → $92 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | — | JMP Securities | Jason Butler51% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/29/2024 | Buy Now | — | Truist Securities | Srikripa Devarakonda43% | $86 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | — | JMP Securities | Jason Butler51% | $106 → $78 | Maintains | Market Outperform | Get Alert |
| 05/23/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $94 → $90 | Maintains | Buy | Get Alert |
| 05/23/2024 | Buy Now | — | B of A Securities | Jason Zemansky77% | $70 → $60 | Maintains | Neutral | Get Alert |
| 05/23/2024 | Buy Now | — | Barclays | Carter Gould56% | $100 → $95 | Maintains | Overweight | Get Alert |
| 05/23/2024 | Buy Now | — | Raymond James | Sean McCutcheon11% | $92 → $70 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | — | Needham | Serge Belanger67% | $108 → $72 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | B of A Securities | Jason Zemansky77% | $75 → $70 | Maintains | Neutral | Get Alert |
| 05/14/2024 | Buy Now | — | JMP Securities | Jason Butler51% | $106 → $106 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | — | Needham | Serge Belanger67% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Needham | Serge Belanger67% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | JMP Securities | Jason Butler51% | $110 → $106 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | Buy Now | — | Oppenheimer | Justin Kim36% | $107 → $106 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | — | Needham | Serge Belanger67% | → $108 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2024 | Buy Now | — | Truist Securities | Srikripa Devarakonda43% | $86 → $86 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $78 → $77 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | — | Mizuho | Salim Syed44% | $103 → $99 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | — | Oppenheimer | Justin Kim36% | → $107 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Needham | Serge Belanger67% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2024 | Buy Now | — | UBS | Ashwani Verma48% | $61 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 01/22/2024 | Buy Now | — | Mizuho | Salim Syed44% | $80 → $103 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | — | B. Riley Securities | Mayank Mamtani71% | $66 → $122 | Maintains | Buy | Get Alert |
| 01/05/2024 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $60 → $90 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/28/2023 | Buy Now | — | Truist Securities | Srikripa Devarakonda43% | $60 → $86 | Maintains | Buy | Get Alert |
| 12/28/2023 | Buy Now | — | Raymond James | Sean McCutcheon11% | $63 → $92 | Maintains | Outperform | Get Alert |
| 12/27/2023 | Buy Now | — | Needham | Serge Belanger67% | $60 → $108 | Maintains | Buy | Get Alert |
| 12/27/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $58 → $94 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | — | Goldman Sachs | Paul Choi58% | → $50 | Initiates | → Buy | Get Alert |
| 11/07/2023 | Buy Now | — | B. Riley Securities | Mayank Mamtani71% | → $66 | Initiates | → Buy | Get Alert |
| 11/01/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | → $58 | Reiterates | Buy → Buy | Get Alert |
| 10/20/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis46% | $49 → $58 | Maintains | Buy | Get Alert |
| 10/20/2023 | Buy Now | — | Needham | Serge Belanger67% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $59 → $65 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | — | JMP Securities | Jason Butler51% | → $71 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/22/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | Buy Now | — | SVB Leerink | Roanna Ruiz37% | → $58 | Initiates | → Outperform | Get Alert |
| 08/04/2023 | Buy Now | — | Needham | Serge Belanger67% | → $60 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Cytokinetics (CYTK) stock?
The latest price target for Cytokinetics (NASDAQ:CYTK) was reported by JP Morgan on June 9, 2025. The analyst firm set a price target for $53.00 expecting CYTK to rise to within 12 months (a possible 60.61% upside). 56 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cytokinetics (CYTK)?
The latest analyst rating for Cytokinetics (NASDAQ:CYTK) was provided by JP Morgan, and Cytokinetics maintained their overweight rating.
When was the last upgrade for Cytokinetics (CYTK)?
The last upgrade for Cytokinetics Inc happened on February 13, 2025 when Morgan Stanley raised their price target to $67. Morgan Stanley previously had an equal-weight for Cytokinetics Inc.
When was the last downgrade for Cytokinetics (CYTK)?
The last downgrade for Cytokinetics Inc happened on August 13, 2024 when Goldman Sachs changed their price target from $85 to $60 for Cytokinetics Inc.
When is the next analyst rating going to be posted or updated for Cytokinetics (CYTK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cytokinetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cytokinetics was filed on June 9, 2025 so you should expect the next rating to be made available sometime around June 9, 2026.
Is the Analyst Rating Cytokinetics (CYTK) correct?
While ratings are subjective and will change, the latest Cytokinetics (CYTK) rating was a maintained with a price target of $71.00 to $53.00. The current price Cytokinetics (CYTK) is trading at is $33.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
